-The Times of India   CHITALIYA (RAJKOT): In the villages of Jasdan taluka in drought-hit Saurashtra, dalit women prefer to remain silent. That's for the fear of the upper castes in a state whose chief minister Narendra Modi is busy trying to conjure up an eclectic image to subserve his perceived prime ministerial ambitions for 2014 polls. "Those people (upper castes) will abuse us again if we speak," mumbled one of the women,...

-The Economic Times The recent patent rulings in India may get frequently challenged in international courts if the government yields to the European Union's demand of including matters related to intellectual property in the investors-state dispute mechanism in their proposed trade pact, health activist groups have warned. An investor-state dispute resolution mechanism typically allows foreign investors to sue countries for compensation if national laws, policies, court rulings of the country infringe upon...

-The Business Standard A CACP study shows how the Fisc, rising farm wages and international forces are stoking inflation It's good to see that independent thought is still present in the government. When one part of the government comes out with a serious and objective piece on how the government itself has been responsible for creating food inflation, hopefully the government is more likely to take note. The Commission for Agricultural Costs and...

-The Indian Express If the BJP finds itself on the back foot today, it isn't because of corruption scandals, but due to the splintering of its social coalition As the stage is set for the state assembly elections in Karnataka, former Prime Minister H.D. Deve Gowda recently made a surprising admission: corruption is not an issue in the upcoming elections, and the precipitous decline in political morality can only be arrested by...

-The Times of India Big pharma may be crying hoarse over India's "weak'' intellectual property environment, but over the past five years or so, they have introduced only a handful of their patented blockbusters in the country. That's not all. The contribution of patented drugs in the Rs 72,000-crore pharma retail market is not even 1%, indicating that multinationals have been traditionally slow and have a poor track record in introducing...